Arsenic trioxide (As 2 O 3 ), used to treat promyelocytic leukemia, triggers cell death through unknown mechanisms. To further our understanding of As 2 O 3 -induced death, we analyzed its effects on transforming growth factor-b (TGFb) signaling mediators in ovarian cells. Dysregulated TGFb signaling is a characteristic of ovarian cancers. As 2 O 3 reduced the protein expression of EVI1, TAK1, SMAD2/3, and TGFbRII while increasing SnoN/SkiL. EVI1 protein was modulated by treatment with the proteasome inhibitors, MG132 and PS-341/Velcade, suggesting that degradation occurs through the ubiquitin-proteasome pathway. The sensitivity of ovarian cells to As 2 O 3 -induced apoptosis correlated with expression of multidrug resistance protein 1. Interestingly, expression of SnoN was similar to LC3-II (autophagy marker), which increased with induction of cytoplasmic vacuolation preceding apoptosis. These vesicles were identified as autophagosomes based on transmission electron microscopy and immunofluorescence staining with EGFP-LC3. The addition of N-acetyl-L-cysteine (ROS scavenger) to As 2 O 3treated cells reversed changes in SnoN protein and the autophagic/apoptotic response. In contrast to beclin-1 knockdown, siRNA targeting ATG5, ATG7, and hVps34 markedly reduced autophagy in As 2 O 3 -treated ovarian carcinoma cells. Further, treatment with SnoN siRNA markedly decreased LC3-II levels and increased PARP degradation (an apoptosis marker). Collectively, these findings suggest that As 2 O 3 induces a beclin-1-independent autophagic pathway in ovarian carcinoma cells and implicates SnoN in promoting As 2 O 3 -mediated autophagic cell survival.
In human ovarian carcinoma cell lines, As 2 O 3 is highly cytotoxic, inducing apoptosis, necrosis, autophagy, and inhibiting invasion. 6, 8, 9 The mechanism of action of As 2 O 3 is unclear. Interestingly, in primary murine leukemia cells, 2-10 mM As 2 O 3 is involved in proteasome degradation of EVI1, a well-known TGFb signaling repressor. 10 To analyze the mechanism of drug-induced cell death, we examined the effects of As 2 O 3 on TGFb signaling mediators in ovarian cells. As 2 O 3 markedly altered protein levels of EVI1, SnoN, TGFbRII, as well as other key TGFb signaling mediators, including SMAD2/3 and AKT. EVI1 protein expression was restored by MG132/PS-341 treatment suggesting that As 2 O 3induced effects on EVI1 is regulated through the proteasome degradation pathway. As 2 O 3 elicited a marked functional effect on cell growth and apoptosis in a number of ovarian cell lines, which correlated with multidrug resistance protein 1 (MRP1) protein expression. siRNA targeting ATG5, ATG7, and hVps34 markedly reduced autophagy in As 2 O 3 -treated ovarian carcinoma cells in contrast to beclin-1 knockdown, which had no effect implicating a beclin-1-independent mechanism in As 2 O 3 -induced autophagy. Moreover, SnoN altered cellular sensitivity to apoptosis by modulating LC3-II levels. Our results implicate SnoN as a potential target for therapy because it promotes cell survival through modulation of autophagy and apoptosis.
Results
As 2 O 3 alters expression of TGFb signaling mediators in ovarian cancer cells. To determine the mechanism of action of As 2 O 3 in ovarian cancer cell lines, we initially determined its effect on the expression of TGFb signaling mediators including EVI1, which is amplified at 3q26.2 in ovarian cancers. 2 We treated HEY and OVCA429 cells (high-EVI1 expressing cell lines) for 18 h with increasing doses of As 2 O 3 (Figure 1a and Supplementary Figure 1a ). As 2 O 3 markedly decreased protein levels of several EVI1 forms in both cell lines including MDS1/EVI1 (which consists of sequences derived from both EVI1 and the MDS1 gene, located telomeric to EVI1), 11 full-length EVI1, and EVI1 Del190À515 (similar to the identified D324 isoform isolated from human endometrial carcinoma cells). 12, 13 In contrast, As 2 O 3 significantly increased SnoN/SkiL levels, also amplified at the 3q26.2 locus in ovarian cancers. 4 Other TGFb mediators markedly reduced by As 2 O 3 treatment include (1) TGFb activating kinase 1 (TAK1), which phosphorylates SnoN targeting it for degradation, 14 (2) SMAD2/3, (3) TGFbRII, which is downregulated in advanced stage ovarian carcinomas relative to normal epithelium 3 (western analysis shows multiple bands likely reflecting heterogeneity of the receptor), and (4) AKT, which can signal through the TGFb pathway by binding to SMAD3. 15 Thus, these data show that As 2 O 3 markedly alters expression of key TGFb signaling mediators in ovarian cancer cells.
As 2 O 3 induces the degradation of TGFb signaling mediators through proteasome-dependent and -independent pathways. To determine whether alterations in expression of TGFb signaling mediators after treatment with As 2 O 3 were due to proteasome-mediated degradation, we performed combinatorial studies with the proteasome inhibitor MG132. We used As 2 O 3 at 5 mM with 5mM MG132, which elicited minimal cellular toxicity compared with higher doses. The response of HEY and OVCA429 to these drug combinations were similar (Figure 1b and Supplementary Figure 1b ). Both EVI1 and EVI1 Del190À515 protein expression were reduced with 5 mM As 2 O 3 whereas there was little effect on MDS1/EVI1 (Figure 1b ). 10 The reduction of EVI1 and EVI1 Del190À515 expression with As 2 O 3 was recovered with MG132, suggesting that As 2 O 3 induces the degradation of certain EVI1 forms through a proteasomemediated pathway. In contrast, TGFbRII was not markedly recovered after 6 or 18 h treatment with MG132, suggesting that As 2 O 3 -induced degradation of TGFbRII likely occurs through a proteasome-independent pathway. Strikingly, SnoN levels were further increased with MG132, suggesting that SnoN protein can be further stabilized through a proteasomemediated pathway. Similar effects were observed with PS-341 (Bortezomid/Velcade), another proteasome inhibitor ( Figure 1c ). SMURF2 (E3 ubiquitin ligase) is involved in geldanamycininduced TGFbRII degradation. 16 However, treatment of OVCA429 and HEY ovarian cancer cells with SMURF2 siRNA (490% reduction in SMURF2 protein) did not significantly alter EVI1, SnoN, or TGFbRII protein in the presence of As 2 O 3 ( Supplementary Figure 1c ) suggesting other E3 ubiquitin ligases are involved in As 2 O 3 -induced degradation of TGFbRII, SnoN, or EVI1.
We next assessed whether As 2 O 3 -induced alterations in AKT, SMAD2/3, and TGFbRII protein with MG132 were due to changes in (1) protein expression independent of the proteasome or (2) RNA levels. MG132 treatment at 18 h not only significantly decreased their protein levels (Figure 1d and Supplementary Figure 1d ), but markedly reduced EVI1 and TGFbRII RNA levels (Figure 1e and Supplementary  Figure 1e ). We also examined the effect of As 2 O 3 on RNA levels ( Figure 1e ) because As 2 O 3 can alter RNA expression such as survivin. 17, 18 However, we observed o20% decrease in EVI1 and TGFbRII RNA levels with little effect on SnoN RNA. Collectively, these results suggest that As 2 O 3 -induced expression changes occur mostly at the protein level.
Decreased sensitivity to As 2 O 3 -induced cell death in ovarian cells expressing high MRP1 protein. To examine the functional effects of As 2 O 3 on both normal and ovarian cancer cells, we assessed its effects on cell growth in (1) T80, a large T antigen/hTERT immortalized normal ovarian surface epithelial cell line (low-expressing EVI1 cell line), (2) HEY (moderate-expressing EVI1 cell line), and (3) SKOV3, (high-expressing EVI1 cell line). 2 We previously reported the expression profile of EVI1 in these ovarian cells. 2 High-expressing EVI1 cells (HEY and SKOV3) were more resistant to effects of As 2 O 3 compared with low-EVI1 expressing cells (T80) based on cell viability assays (Figure 2a ). On microscopic examination, we observed that these cells developed numerous cytoplasmic vacuoles and were apoptotic as evidenced by apoptotic morphology and substratum release ( (a) HEY cells were seeded at 250 000 cells per well in six-well plates. After overnight attachment, the cells were treated with varying concentrations of As 2 O 3 (2-50 mM). After 18 h incubation, the cell lysates were harvested and western analysis was performed using the following antibodies: (1) EVI1, (2) SnoN, (3) TAK1, (4) TGFbRII, (5) SMAD2/3, (6) AKT, and (7) GAPDH as a loading control. The data shown are representative of four independent experiments. (b) HEY cells were seeded at 250 000 cells per well in six-well plates. After overnight attachment, the cells were treated with (1) 5 mM As 2 O 3 , (2) 5 mM MG132, or (3) 5 mM As 2 O 3 and 5 mM MG132. After 6 or 18 h treatment, the cell lysates were harvested and western analysis was performed using the following antibodies: (1) EVI1, (2) SnoN, (3) TGFbRII, (4) SMAD2/3, (5) AKT, and (6) GAPDH as a loading control. The data shown are representative of three independent experiments. (c) HEY cells were seeded at 250 000 cells in six-well plates. After overnight attachment, the cells were treated with (1) 10 mM As 2 O 3 , (2) 500 nM PS-341, or (3) 10 mM As 2 O 3 and 500 nM PS-341. After 6 or 18 h treatment, the cell lysates were harvested and western analysis was performed using the following antibodies: (1) EVI1, (2) SnoN, (3) TGFbRII, (4) SMAD2/3, (5) AKT, and (6) GAPDH as a loading control. The data shown are representative of three independent experiments. (d) HEY cells were seeded at 250 000 cells per well in six-well plates. After 24 h, the cells were treated at different time points (1, 3, and 18 h) with 5 mM MG132. Cell lysates were harvested and western analysis was performed using the following antibodies: (1) EVI1, (2) SnoN, (3) TGFbRII, (4) SMAD2/3, (5) AKT, and (6) GAPDH as a loading control. The data shown are representative of three independent experiments. (e) HEY cells were seeded at 500 000 cells per well in six-well plates. After 24 h, the cells were treated with (1) DMSO, (2) 5 mM As 2 O 3 and DMSO, or (3) 5 mM MG132 for 18 h. RNA was then isolated and used for qPCR. Relative RNA-fold changes are presented for EVI1, SnoN, and TGFbRII. The data shown are representative of three independent experiments V-FITC and propidium iodide (PI) to quantify changes in apoptosis indicated that, after As 2 O 3 treatment, normal ovarian cells (T80) had a markedly higher apoptotic percentage (480%) compared with ovarian cancer cells (SKOV3 and HEY; o20%) ( Figure 2c ). These results indicate that normal ovarian cells (T80) are more sensitive to As 2 O 3induced apoptosis compared with cancer cells (HEY and SKOV3). In contrast, As 2 O 3 reduced the migratory potential Figure 2 ). As As 2 O 3 has been reported to reduce intracellular glutathione (GSH) levels, 19 we next assessed whether GSH levels in T80, HEY, and SKOV3 cells may be correlated with the sensitivity to As 2 O 3 . All cell lines had reduced GSH levels after As 2 O 3 treatment with markedly reduced levels in normal immortalized ovarian T80 cells compared with HEY and SKOV3 ( Figure 2d ). As GSH can bind to trivalent arsenic and is effluxed out of cells through MRP1, 20 we thus analyzed the level of MRP1 protein in these ovarian cell lines. Indeed, we found that MRP1 was highly expressed in SKOV3 and HEY cells (highly resistant to As 2 O 3 -mediated effects) and low in T80 cells (Figure 2e ). Together, these results suggest that the decreased sensitivity to As 2 O 3 in ovarian carcinoma cells may be due to increased efflux of GSH-As 2 O 3 through MRP1.
As 2 O 3 induces formation of autophagosomes. As formation of cytoplasmic vacuoles with As 2 O 3 treatment was suggestive of induction of autophagy (see Figure 2b ), we first examined protein expression of microtubule-associated protein light chain 3 (LC3), a marker of autophagic vesicle formation. As 2 O 3 increased levels of both the LC3-I (cytosolic form, 18 kDa) and LC3-II (membrane-bound form, 16 kDa), which correlated with SnoN expression at 10-25 mM in T80/ HEY cells and 425 mM in SKOV3 cells ( Figure 3a ). p62/ SQSTM1, which recruits autophagic machinery to inclusion bodies as a protective response for clearing protein aggregates through the autophagic pathway, 21 also increased in a dose-dependent manner. In addition, poly (ADP-ribose) polymerase (116 kDa, PARP), which is proteolytically fragmented to 89 and 24 kDa (early marker of apoptosis) by caspase-3, which precedes DNA fragmentation, dramatically increased at a dose of 25 mM (T80) and 50 mM (HEY and SKOV3) correlating with the apoptotic sensitivity determined by Annexin V staining (see Figure 2c ).
As the development of cytoplasmic vacuoles at 18 h treatment preceded apoptosis as determined by light microscopy ( Figure 3b ), we performed a kinetic profile to follow these events in a time-dependent manner with respect to expression of TGFb mediators ( Figure 3c ). We observed induction of SnoN at 9 h As 2 O 3 treatment, which correlated with changes in LC3-II and p62. We observed dramatic decreases in EVI1, TAK1, SMAD2/3, and TGFbRII expression levels at 18 h treatment, which correlated with marked increases in the LC3-I/II ratio as well as reduction in procaspase-3 and increased cleaved PARP. Induction of another potential splice variant of EVI1 (B60 kDa, detected using an antibody, which detects multiple splice forms of EVI1) followed levels of cleaved PARP. These results provide evidence for the correlation of the induction of expression of SnoN with the autophagic marker, LC3-II, which precedes changes in apoptotic markers. Interestingly, beclin-1 levels did not increase but decreased after 18 h treatment.
We next identified the presence of autophagosomes by transmission electron microscopy (TEM). By TEM, we positively identified the presence of numerous doublemembrane autophagosomes with As 2 O 3 treatment (Figures 3d and e ). After 3 h As 2 O 3 treatment, formation of double-membrane structures was observed. At 9 h, autophagosomes were fully formed and at 18 h, clearing within autophagosomes was observed suggesting degradation of the cytoplasmic contents ( Figure 3e ). Beyond 18 h, the cells underwent apoptosis (results not shown). In addition, we transfected EGFP-LC3 cDNA into HEY cells to identify fluorescent vacuoles after As 2 O 3 treatment and observed a punctate staining pattern around the nucleus with 5 mM to 25 mM As 2 O 3 compared with diffuse EGFP fluorescence in untreated cells (0 mM As 2 O 3 ) (see Figures 5a and b). Collectively, these results show that As 2 O 3 induces the development of autophagosomes in parallel with induction of SnoN protein, which precedes changes in apoptotic markers.
As 2 O 3 mediates its effects in ovarian cells through the generation of reactive oxygen species (ROS).
To determine whether the As 2 O 3 -induced changes observed in expression of TGFb signaling mediators are due to the effects of oxidative stress, we treated HEY cells with As 2 O 3 in combination with the antioxidant N-acetyl-L-cysteine (NAC), a free radical scavenger/reducing agent and GSH precursor, which protects against As 2 O 3 -induced apoptosis in tumor cells. 22 Light micrographs of cells co-treated with 10 mM As 2 O 3 and 1000 mM NAC showed a dramatic reduction in cytoplasmic vacuolation and apoptotic morphology in contrast to cells treated with 10 mM As 2 O 3 alone ( Figure 4a ). Further, increasing doses of NAC markedly reduced SnoN with a corresponding recovery in EVI1 and TGFbRII proteins (Figure 4b , left panel). The results indicate that TGFb signaling mediator expression can be altered by the presence of ROS. Although the levels of p62 remained unchanged or increased slightly, there was a reduction in LC3-I levels (Figure 4b , right panel). Further, we observed a dramatic reduction in punctate EGFP-LC3 staining suggesting As 2 O 3 -induced autophagy can be . We observed an increase in cell survival after co-treatment with 10 mM As 2 O 3 and 1000 mM NAC ( Figure 4d ) indicating that NAC promotes increased cellular viability. As the level of cleaved PARP was difficult to detect at 10 mM As 2 O 3 (Figure 4b , right panel), we quantified changes in apoptosis by staining with annexin V-FITC and PI. We observed a significant decrease in apoptotic cells on co-treatment with 10 mM As 2 O 3 and NAC compared with As 2 O 3 -only treated cells (Figure 4e ). Together, these results suggest that As 2 O 3 mediates its effects through the generation of ROS, which alters the autophagic and apoptotic response.
As 2 O 3 induces autophagy through a beclin-1independent pathway. To determine whether autophagy is a necessary step in induction of cell death through As 2 O 3 , we tested the effects of various inhibitors of autophagy and apoptosis. 3-Methyladenine (3-MA) is a class III phosphatidylinositol-3-kinase (PI3K) inhibitor that inhibits autophagy at the earliest stage of autophagosome formation and is associated with decreased LC3-II expression. 23 Although SnoN levels were not dramatically altered in HEY cells co-treated with As 2 O 3 and 3-MA, there was reduced formation of EGFP-LC3 punctae (Figures 5a and b) , decreased LC3 protein, and increased cleaved PARP (used as marker of apoptosis) in contrast to cells treated with 25 mM As 2 O 3 alone ( Figure 5c ). Although beclin-1 levels were previously reported to be suppressed by 3-MA treatment, 24 we did not detect any marked changes in beclin-1 levels in HEY cells co-treated with 3-MA and As 2 O 3 (Figure 5c ). Moreover, addition of 3-MA to resveratrol-treated ovarian cells failed to elicit a marked change in beclin-1 or LC3 expression ( Supplementary Figures 3a and b) . In contrast, nutrient starvation with EBSS markedly increased both LC3 and beclin-1 levels, which were both reduced after treatment with 3-MA ( Supplementary Figures 4a and b ). We next analyzed the effect of bafilomycin A1 (BAF), a late-stage autophagy inhibitor that hinders fusion of lysosomes to autophagosomes leading to inhibition of the degradation of inner contents and accumulation of uncleaved LC3-II protein. 25 Western analysis of HEY cells co-treated with As 2 O 3 and BAF showed increased LC3-II and cleaved PARP levels (Figure 5d , left panel). These results suggest that inhibition of late stage autophagy leads to increased apoptosis. Further, SnoN levels were slightly reduced with BAF in the presence of As 2 O 3 suggesting a role for SnoN in this process. In addition, we analyzed the effect of zVAD-fmk, a caspase inhibitor, which inhibits apoptosis, to provide additional evidence that As 2 O 3 -induced autophagy is independent of apoptosis. 26 Although the levels of SnoN and LC3 remained unchanged with increasing concentrations of zVAD-fmk ( Figure 5d , right panel), cleaved PARP was markedly reduced suggesting decreased apoptosis. Collectively, these results suggest that As 2 O 3induced autophagy confers a protective role against apoptosis, which is the primary cell death mechanism induced by As 2 O 3 . As these inhibitors can induce nonspecific effects, we thus assessed knockdown of specific ATG genes on autophagy and apoptosis in HEY cells. Several key regulators of autophagy were detectable by western analysis in ovarian cells such as hVps34, beclin-1, ATG5, and ATG7 ( Figure 5e ). Although knockdown of beclin-1 by siRNA treatment for 2 consecutive days effectively (495%) reduced protein expression ( Figure 5f ), it did not affect expression of LC3-II/ LC3-I ( Figure 5f ) or significantly modulate formation of LC3 punctae induced by As 2 O 3 (Figures 5g and h) . In contrast, ATG5, ATG7, and hVps34 siRNA markedly altered the ratio of LC3-II/LC3-I ( Figure 5f ) and LC3 punctae formation (Figures 5g and h). Staining with annexin V-FITC and PI showed only subtle changes in the apoptotic response with ATG siRNAs (Figure 5i ). Furthermore, we assessed beclin-1 knockdown with EBSS treatment, which led to reduced LC3-II levels ( Supplementary Figure 4c ). However, we could not accurately assess the effect of EBSS on LC3 punctae formation because of the dramatically altered cell morphology (i.e., cell rounding). Together, these results suggest that As 2 O 3 elicits its effects on autophagy in a beclin-1-independent manner.
Modulation of the sensitivity of ovarian cancer cells to As 2 O 3 by SnoN knockdown. As we observed that SnoN levels paralleled those of LC3, we analyzed whether SnoN could alter LC3-II levels and production of autophagosomes. Light microscopy suggests that knockdown of SnoN increases the sensitivity of the cells to As 2 O 3 treatment leading to increased cell death compared with control siRNAtreated cells (Figure 6a ). In SnoN knockdown cells (490% decrease in SnoN protein) treated with As 2 O 3 , western analysis showed a marked reduction in LC3-II and p62 levels with an increase in cleaved PARP compared with control siRNA cells treated with 25 mM As 2 O 3 (Figure 6b ). These protein changes corresponded with a reduction in EGFP-LC3 punctae (Figure 6c ), a marked reduction in cell survival (Figure 6d ), and increased levels of apoptosis determined by annexin V-FITC and PI staining (Figure 6e ). Thus, these data suggest that the sensitivity to As 2 O 3 -induced autophagy and apoptosis can be modulated by altering SnoN levels.
qPCR measurements of LC3 RNA transcripts indicated that its levels are low and SnoN siRNA did not modulate LC3 RNA transcripts (results not shown) suggesting alternative mechanisms other than direct transcriptional regulation of LC3 by SnoN. As low-and high-expressing EVI1 ovarian cell lines differed in their response to the apoptotic effects of As 2 O 3 (see Figures 2a and b) , we assessed the effect of EVI1 siRNA on the sensitivity of ovarian cancer cells to As 2 O 3 . However, EVI1 siRNA (490% reduction in wild-type EVI1 protein) did not dramatically alter As 2 O 3 -induced sensitivity to apoptosis based on PARP cleavage levels or alter autophagy based on western analysis of LC3-II levels (results not shown).
SnoN is reported to be degraded on TGFb stimulation by TAK1 through the ubiquitin-dependent proteasome pathway. 14 As we observed that As 2 O 3 treatment decreased TAK1, we next assessed whether reducing TAK1 levels could alter As 2 O 3 -induced changes in SnoN and thus, modulate the autophagic pathway. However, TAK1 siRNA treatment (480% knockdown) did not modulate SnoN levels, alter the sensitivity of ovarian cancer cells to As 2 O 3 , or modulate p62 and LC3 protein levels (Figure 7a ). However, knockdown of AKT, which lies downstream to PI3K 27 and is a promising target for therapy in ovarian carcinomas, 28, 29 did not modulate expression of TGFb signaling mediators, but did increase PARP cleavage while decreasing p62 levels and LC3-II/LC3-I levels (Figure 7b) suggesting that AKT has a role in modulating the apoptotic and autophagic pathways.
Discussion
As successful treatment of cancer cells with chemotherapeutic drugs is dependent on their ability to trigger cell death, it is critical to understand their mechanisms of action. In this study, we report that As 2 O 3 , commonly used to treat APL, can target TGFb signaling mediators through proteasomedependent (i.e., EVI1 and TGFbRII) and -independent pathways (SMAD2/3 and AKT) in ovarian cancer cell lines. The increased sensitivity of EVI1 forms to As 2 O 3 after longterm treatments (18 h) could be due to their inherent protein stability and long half-life. These As 2 O 3 -induced effects on EVI1 are similar to the reported effects in leukemia cell lines. 10 In our studies, we observed different sensitivities to As 2 O 3 among the three ovarian cell lines assessed (low-(T80) and high-(SKOV3 and HEY) expressing EVI1 ovarian cell lines) suggesting that the sensitivity of ovarian cell lines to As 2 O 3 may correlate with EVI1 protein expression. However, knockdown of EVI1 (siRNA designed against exon VII) failed to alter the sensitivity to As 2 O 3 -induced apoptosis. There are numerous other factors likely dictating cellular resistance or sensitivity to As 2 O 3 including (1) GSH levels, (2) enzymes involved in biosynthesis of GSH, (3) enzymes using GSH (glutathione-S-transferase), (4) free radical scavenging and peroxide metabolism (GSH peroxidase, catalase), and (5) MRP1 levels, which is involved in the efflux of As 2 O 3 in drug-resistant cell lines. Indeed, we observed that MRP1 is highly expressed in both HEY and SKOV3 cells, which could result in resistance to As 2 O 3 .
As 2 O 3 treatment dramatically elevated SnoN levels likely mediated through a ROS-dependent pathway (Figure 4b ).
As 2 O 3 treatment can generate ROS, a form of oxidative stress, which can induce autophagy. Superoxide anion appears to be the major ROS regulating autophagic process. 30 As ROS oxidizes cellular lipids, proteins, and DNA causing cellular damage, autophagy serves to prevent accumulation of these damaged toxic products and organelles by sequestering these cellular components into autophagosomes (double-membraned vesicles), which fuse with lysosomes for degradation. Specifically, ROS can oxidize the cysteine protease, ATG4, involved in initiating the conjugation of LC3-I to autophagosomal membranes and its consequent release from the autophagophore membrane. 31 We also observed that As 2 O 3 treatment elevated SnoN levels in a TAK1-independent manner (Figure 7a ). Interestingly, normal epithelial cells treated with TRAIL induced cytoprotective autophagy mediated through TAK1, which activates AMP-activated protein kinase leading to inhibition of mammalian target of rapamycin I. 32 However, under our assay conditions, we did not detect changes in autophagy or apoptosis on depletion of TAK1 in HEY ovarian carcinoma cells (see Figure 7a ).
Signaling pathways determining whether cells undergo autophagy or apoptosis are complex. In malignant glioma cells, As 2 O 3 seems to initiate an autophagic response that leads to cell death. 33 This contrasts to our data in ovarian cell lines based on inhibitor studies with 3-MA and zVAD-fmk suggesting cell-type-specific effects of As 2 O 3 . Indeed, autophagy has been described as a 'double-edged sword' promoting (1) survival in response to stress and starvation as well as (2) programmed cell death. 34 Recently, autophagyrelated proteins such as beclin-1 or ATG5/12 do not seem to be required for the autophagic process suggesting alternative non-canonical macroautophagy pathways. 35, 36 In our ovarian carcinoma cells, beclin-1 seemed to be dispensable for inducing As 2 O 3 -mediated autophagic response but was dependent on hVps34.
SnoN protein not only paralleled the autophagy marker (LC3-II) but knockdown of SnoN altered LC3-II/I ratios suggesting that this protein lies downstream to SnoN. Other mediators important in As 2 O 3 -induced programmed cell death include p21, which itself leads to cell cycle arrest and apoptosis. 37 Indeed, we have previously shown that SnoN knockdown increases p21 protein levels. 4 Thus, SnoN may have a key role in autophagy to promote cell survival as a protective mechanism against As 2 O 3 -induced cell death (Figure 8 ). The mechanism by which SnoN alters autophagosome development is presently under investigation.
Materials and Methods
Cell lines and cell culture. The following ovarian cell lines were used for the studies reported herein: T antigen/hTERT immortalized normal ovarian surface epithelial cells (T80) as well as several ovarian carcinoma cell lines, including SKOV3 (amplification at the EVI1 locus), HEY (high-expressing EVI1 cell line), and OVCA429 (high-expressing EVI1 cell line). 2 Cell lines were cultured in RPMI 1640 with 8% FBS and penicillin/streptomycin and maintained in an incubator with a humidified atmosphere containing 95% air and 5% CO 2 at 37 1C. For nutrient starvation, cells were washed three times with Earle's balanced salt solution (EBSS) (Invitrogen, Carlsbad, CA, USA) and then replaced with EBSS.
siRNA treatment of ovarian cell lines. The ovarian cancer cells, HEY and OVCA429, were plated at 250 000 cells (unless otherwise specified) in each well of a six-well plate. The following day, the cells were transfected using 20 mM siRNA against SnoN (Ambion, Austin, TX, USA), ID#107696 or ID#107695), EVI1 exon VII (Dharmacon, Lafayette, CO, USA), custom-designed sequence: sense 5 0 -ACUACGUCUUCCUUAAAUAUU-3 0 ), AKT (Cell Signaling Technology, Danvers, MA, USA), TAK1 (Dharmacon, custom-designed sequence: sense 5 0 -GUAGAUCCAUCCAAGACUUUU-3 0 ), SMURF2 (Dharmacon, L-007194-00), ATG5 (Dhamarcon, L-004374-00), beclin-1 (Dharmacon, L-010552-00), ATG7 (Dharmacon, L-020112-00), hVps34 (Applied Biosystems, Foster City, CA, USA, ID#10517), or non-targeting control-1 siRNA (Dharmacon, D-001210-01) using Dharmafect I transfection reagent (Dharmacon). Briefly, cells were cultured in complete medium for 24 h before transfection (2 ml media in each well of six-well plate) at which time the medium was changed to serum and antibiotic-free medium. Dharmafect I (4 ml) was incubated in 100 ml of serum and antibiotic-free media for 10 min at room temperature, followed by the addition of 5 ml of siRNA (20 mM) and further incubated for 20 min at room temperature. The mixture was added to the cells and incubated for 48 h before isolation of RNA and protein for qPCR and western analysis, respectively. Ovarian cells were plated in six-well plates at 250 000 cells per well and grown in complete medium. The following day, the cells were treated with 5 mM MG132, As 2 O 3 (between 2 and 50 mM), resveratrol (between 10 and 100 mM), NAC (between 25 mM and 1 mM), 3-MA (between 0.1 and 10 mM), or zVAD-fmk (25 and 100 mM). For detection of apoptosis by western analysis, it was generally difficult to detect cleaved PARP at 10 mM As 2 O 3 treatment but it was clearly observable with 25 mM As 2 O 3 (see Figure 3a ). For functional assays (cell viability, apoptosis by PI/Annexin V staining, and EGFP-LC3 staining), we treated cells with 10 mM As 2 O 3 , which allowed detection of differences more clearly with various treatments including siRNA knockdown (see Figure 2c ). For control cells, DMSO (a final concentration of o0.5%) was added to compare appropriately with drugs dissolved in DMSO. After the appropriate incubation time (6 or 18 h), cell lysates were collected, protein quantified, and SDS-PAGE/western analysis was performed. In addition, for selected studies, RNA was isolated, quantified, and used for qPCR analysis.
Quantitative PCR. RNA was isolated using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Quantitative PCR (qPCR) was performed using the one-step RT-PCR Taqman master mix from Applied Biosystems with the following primers and probe sets. Figure 7 AKT knockdown modulates apoptosis in response to As 2 O 3 . (a) HEY cells were seeded at 375 000 cells per well in six-well plates. After 24 h attachment, cells were transfected with either non-targeting (control) or TAK1 siRNA. Transfected cells were then treated for 18 h with (1) 10 mM As 2 O 3 , (2) 10 mM As 2 O 3 with 1 mM NAC, and (3) 50 mM As 2 O 3 . Cell lysates were harvested and western analysis was performed using the following antibodies (1) EVI1, (2) SnoN, (3) TAK1, (4) PARP, (5) LC3, (6) p62, and (7) GAPDH as a loading control. The data shown are representative of two independent experiments. (b) HEY cells were seeded at 375 000 cells per well in six-well plates. After 24 h attachment, cells were transfected with either non-targeting (control) or AKT siRNA. Transfected cells were then treated for 18 h with (1) 10 mM As 2 O 3 , (2) 10 mM As 2 O 3 with 1 mM NAC, and (3) 50 mM As 2 O 3 . Cell lysates were harvested and western analysis was performed using the following antibodies: (1) EVI1, (2) SnoN, (3) TAK1, (4) AKT, (5) PARP, (6) LC3, (7) p62, and (8) GAPDH as a loading control. The data shown are representative of two independent experiments Figure 8 Therapeutic potential for SnoN in mediating As 2 O 3 -induced autophagic cell survival. As 2 O 3 diffuses into the cell through the cell membrane leading to a reduction in intracellular GSH levels and an increase in ROS which through unknown mechanisms lead to increases in SnoN levels. SnoN alters LC3-II expression, a marker of autophagosome maturation, suggesting that SnoN can induce autophagy. Induction of autophagy seems to be a protective mechanism of cell survival following As 2 O 3 treatment in ovarian cells. In high MRP1-expressing cell lines, As 2 O 3 is effluxed through these channels resulting in reduced sensitivity to As 2 O 3 -induced apoptosis then fixed in 4% formaldehyde in PBS for 30 min at room temperature, washed twice in PBS, and blocked for 1 h at room temperature in PBS containing 5% goat serum and 0.1% Triton X-100. The cells were washed three times for 5 min in PBS, anti-Fade containing DAPI nuclear stain was then applied, coverslips mounted onto glass slides and viewed under a Zeiss (Carl Zeiss Incorporated, Thornwood, NY, USA) inverted fluorescence microscope (Moffitt Cancer Center Microscopy Core). Quantification of EGFP-LC3-expressing cells was assessed by counting the number of cells containing punctate dots in a total of 200 EGFP-LC3-positive cells.
For indirect immunofluorescence of endogenous LC3B expression, HEY cells fixed in 4% formaldehyde in PBS for 30 min at room temperature, washed twice in PBS, and blocked for 1 h at room temperature in PBS containing 5% goat serum and 0.1% Triton X-100. Primary antibodies (LC3B used at 1 : 2000 dilution) were incubated in PBS containing 1% goat serum and 0.1% Triton X-100 overnight at 4 1C. The cells were washed three times for 5 min in PBS and then incubate with the appropriate cy3-fluorescent-conjugated rabbit antibody for 1 h in PBS containing 1% goat serum and 0.1% Triton X-100. The cells were washed three times for 5 min in PBS, anti-Fade containing DAPI nuclear stain was then applied, coverslips mounted onto glass slides, and viewed under a fluorescence microscope.
GSH measurement assays. GSH was measured using the GSH-Glo kit (Promega). Briefly, T80, HEY, and SKOV3 ovarian cells were plated at 5000 cells per well in opaque white 96-well plates. After overnight attachment, cells were treated with As 2 O 3 for 18 h. After cell treatments, the media was discarded and fresh PBS was added for washout followed by the addition of 100 ml of GSH-Glo reagent. After a 2-min shake, the cells were incubated at room temperature for 30 min followed by the addition of reconstituted luciferase detection reagent. The cells were incubated for a further 15 min at room temperature and the plate was read on a Biotek luminescence plate reader. All measurements were performed in triplicate.
Statistical analyses. Values are reported as the mean ± S.D. of independent experiments (see Figure legends) . In cell viability assays, the data are normalized to control cells and expressed as the percentage of live cells relative to total cells.
